Exhibit 23.1

Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Jyong Biotech Ltd. on Amendment No. 1 to Form F-1 (File No. 333-274042) of our report dated March 15, 2023, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the consolidated financial statements of Jyong Biotech Ltd. as of December 31, 2021 and for the year ended December 31, 2021. We also consent to the reference to our firm under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
We resigned as auditors in June 2023 and, accordingly, we have not performed any audit or review procedures with respect to any financial statements included in this Registration Statement for the periods after the date of our resignation.
/s/ Marcum Asia CPAs LLP
New York, New York
October 18, 2023
NEW YORK OFFICE • 7 Penn Plaza • Suite 830 • New York, New York • 10001
Phone 646.442.4845 • Fax 646.349.5200 • www.marcumasia.com